Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
about
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsisJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statinsStabilization of high-risk plaquesExploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular DiseaseUltrasound assessment of carotid plaque echogenicity response to statin therapy: a systematic review and meta-analysis.Cerebral cavernous malformation is a vascular disease associated with activated RhoA signalingTargeting NADPH oxidases in vascular pharmacologyA novel therapeutic effect of statins on nephrogenic diabetes insipidusAtherogenesis in perspective: hypercholesterolemia and inflammation as partners in crimeStatins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretionIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesSynergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblastsPDGF-induced proliferation of smooth muscular cells is related to the regulation of CREB phosphorylation and Nur77 expressionStatins potently reduce the cytokine-mediated IL-6 release in SMC/MNC coculturesLDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline.Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.A review of drug options in age-related macular degeneration therapy and potential new agents.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice.Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.Monomethylarsonous acid inhibited endogenous cholesterol biosynthesis in human skin fibroblasts.Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasisA new mouse model to explore therapies for preeclampsia.Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells.Associations between apolipoprotein CIII concentrations and microalbuminuria in type 2 diabetes.Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study.Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injuryEffect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced NephropathyFlow, NO, and atherogenesisLovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis.Hypercholesterolemia and microvascular dysfunction: interventional strategies.Statins and prostate cancer risk: a case-control study.Pharmacological potential of tocotrienols: a review.Fractional flow reserve is not associated with inflammatory markers in patients with stable coronary artery diseaseSimvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension.The Anti-Inflammatory Actions of Exercise Training
P2860
Q24193361-121C251A-482E-469A-A530-A123E318EDE7Q24630160-D86CC20D-E6C0-46F0-87B6-10DF3E3944AAQ24684244-1FF1D026-DAC6-4A2A-9123-D6A795395BF7Q26738584-1735B8B0-7FF1-4220-97A0-59308FB3626EQ26801173-B7E75BD5-ACDC-4C98-AAF8-19F4E6747072Q26828967-37BA71AB-A243-422C-B001-027814908B62Q26849566-9DE34DCE-0C43-4BDA-AF23-F98A0C26838BQ26863500-292BA1D5-5905-4D38-86E3-C22262CD10C6Q27005638-BAB23F54-F680-4796-A080-0B2C72AF3318Q28212769-493FA9A6-D042-460A-B257-1A235CAB9B05Q28294279-A7FC4646-E3D4-45E2-B1FB-D0D511CBF947Q28388335-FE6C4CBE-D4E7-4CB7-9C00-951B6ABFF404Q28569888-0113741A-4083-468D-AD39-8CEDCFF1921DQ28575756-0DD0141D-F8F9-4A34-8079-CED7C1B07625Q30318772-40F2CD93-DC2B-4F6A-BA54-4400635AD2C7Q30422549-2B67CC0A-E25E-4DDA-BB8D-111EA390CE2AQ30425097-F69A94E3-7C76-466F-9212-D25C0456EFE2Q30430614-94D6EF7E-2195-4AAF-AB1A-75672F203DA4Q33187638-BEA11993-1E34-41EE-BC28-8B057C3E6480Q33263803-FD1312D1-00E1-4F18-9C69-1CF483A52888Q33585657-50172072-ECB8-4777-93E8-9F93F31EE8B7Q33610240-550EA5F9-CB91-40BB-9842-208B99220105Q33620009-630D8C30-BCAC-4964-83BA-BA53195C4957Q33633640-1121B603-8181-4A76-B0C9-E620F3C8E8A7Q33683916-084D2AF7-BD3D-449F-8F43-D2E248DB51D1Q33684159-CFEBD035-2557-4D2D-892F-5508307CAFF2Q33737551-E9A2D704-F2BB-4726-8FEF-DC6C33634699Q33767224-7DA7ACDB-2D7B-47FD-90DF-4EDE40E3F6D4Q33962626-8BDA3DED-CBBF-4DEE-A448-B04F2BC35C46Q34081786-980610BD-90C6-4C27-A7C9-D14F1CE8514DQ34146989-31091CAD-0728-45AB-830B-ECB312572E42Q34269645-4D39A2D3-7B07-4664-B48C-26505A40B9B8Q34327487-D32A70E5-43C6-4C71-991A-EDA04AA87B31Q34350784-1B44FD29-D75D-45CA-B4E6-BEF24E728275Q34375542-DFB0955A-315D-4D8B-A36C-BFF9A66FCD65Q34433638-AB4C498A-3217-4066-B6C5-969F018E8AAEQ34450166-70D3003F-463A-4F36-80AB-A678006B5AB8Q34455082-0A67C2C6-0D72-4F90-B1F7-1CD1294492DEQ34512580-A9305AB8-3B6E-4A3F-BC3E-7F31051A44BEQ34569544-EBA392D0-C5A1-4BA2-A400-B15B9C5D64FE
P2860
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@ast
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@en
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@nl
type
label
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@ast
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@en
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@nl
prefLabel
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@ast
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@en
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@nl
P356
P1476
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
@en
P2093
P304
P356
10.1161/HQ1101.098486
P407
P577
2001-11-01T00:00:00Z